Urolog. pro Praxi, 2008; 9(1): 33-35

Predikční nomogramy u karcinomu prostaty

MUDr. Milan Král, doc. MUDr. Vladimír Študent Ph.D, MUDr. Martin Hrabec
Urologická klinika FN a LF UP v Olomouci

Sdělení uvádí přehled nejčastěji užívaných předpovědních tabulek a nomogramů u karcinomu prostaty. Jejich zapojení do praxe by mělo být v dnešní době již standardem, neboť napomáhají v rozhodovacím algoritmu nejen lékaři, ale také pacientovi. Správné odhadnutí případných rizik (pozitivní okraje, invaze vezikul, biochemické selhání po původně kurativní léčbě a další) nám umožňuje optimalizovat terapii s ohledem na radikalitu léčby i pacientovy preference.

Keywords: karcinom prostaty, predikce, nomogram, léčba

Published: April 1, 2008  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Král M, Študent V, Hrabec M. Predikční nomogramy u karcinomu prostaty. Urol. praxi. 2008;9(1):33-35.
Download citation

References

  1. D' Amico AV, Whittington R, Malkowicz SB, Cote K, Loffredo M, Schultz D, Chen MH, Tomaszewski JE, Renshaw AA, Wein A, Richie JP. Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era. Cancer. 2002 Jul 15; 95 (2): 281-286. Go to original source... Go to PubMed...
  2. Epstein JI, Allsbrook WCJ, Amin MB, Egevad LL, and The ISUP grading committee (2005a). Consensus conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol 2005; 29: 1228-1242. Go to original source... Go to PubMed...
  3. Han M, Partin AW, Zahurak M et al. Biochemical (PSA) recurrence probability following radical prostatectomy for clinically localized prostated cancer. J Urol 2003, 169: 517-523. Go to original source...
  4. http://www.mskcc.org.
  5. Chun FKH et al. Postoperative nomogram predicting the probability of biochemical recurrence-free survival after radical prostatectomy. In: Karakiewicz. Convenience in prostate cancer risk assessment. 2006, http://lip.bioinfo.pl/pmid:16705126. Go to original source...
  6. Kattan MW, Wheeler TM, Scardino PT. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol, 1999; 17(5): 1499-1507. Go to original source... Go to PubMed...
  7. Kattan MW, Zelefsky MJ, Kupelian PA, Cho D, Scardino PT, Fuks Z, Leibel SA. Pretreatment nomogram that predicts 5-year probability of metastasis following three-dimensional conformal radiation therapy for localized prostate cancer. J Clin Oncol, 2003; 21(24): 4568-4571. Go to original source... Go to PubMed...
  8. Karakiewicz PI. Convenience in prostate cancer risk assessment. Nomograms for doctors, September 2006, Internet - u autora.
  9. Makarov DV, Trock BJ, Humphreys EB, Mangold LA, Walsh PC, Epstein JI, Partin AW. Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005. Urology, 2007; 69(6): 1095-1100. Go to original source... Go to PubMed...
  10. Partin AW, Kattan MW, Subong EN, Walsh PC, Wojno KJ, Oesterling JE, Scardino PT, Pearson JD. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA, 1997; 277 (18): 1445-1451. Go to original source... Go to PubMed...
  11. Partin AW, Mangold LA et al. Contemporary update of prostate cancer staging nomogram for the new millenium. Urology, 2001; 58: 843-848. Go to original source... Go to PubMed...
  12. Remzi M, Fong YK, Dobrovits M, Anagnostou T, Seitz C, Waldert M, Harik M, Marihart S, Marberger M, Djavan B. The Vienna nomogram: validation of a novel biopsy strategy defining the optimal number of cores based on patient age and total prostate volume. J Urol, 2005; 174 (4 Pt 1): 1256-1260. Go to original source... Go to PubMed...




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.